Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase (PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid (Abeta) was directly involved in PAK signaling deficits and drebrin loss in Abeta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher Abeta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ oligomers reduce activity of LIMK, which in turns leads to dephosphorylated, active cofilin, depolymerization of actin filaments and the generation of actin rods [66].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [66]
In the citing paper
“In the hippocampus of individuals with Alzheimer’s disease and in animal models of Alzheimer’s disease, PAK activation is markedly reduced and mislocalized69.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [69]
In the citing paper
“A critical regulator of actin assembly in spines is p21-activated kinase (PAK), a downstream effector molecule of Rac69,70.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [69]
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Dendritic regression and spine loss per remaining neurite have been observed in Alzheimer disease with traditional Golgi stainin”
BackgroundCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“Aβ oligomers cause PAK signaling defects To directly test the hypothesis that Aβ oligomers can cause PAK signaling defects, we incubated cultured primary hippocampal neurons with 100 ng ml −1 of soluble Aβ1–42 aggregates prepared with an Aβ oligomer–generating protoco”
MethodAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498 · cited 1×
“Passive Aβ antibody treatment increases Tg2576 pPAK To further examine the possible role of Aβ in PAK deficits, we reduced the amount of Aβ with an approach that has been consistently demonstrated to clear Aβ and reverse cognitive deficits in App swe Tg mice—passive immunization with an anti-Aβ antibody recognizing th…”
BackgroundRegulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O., & Caroni, P. (1998) · Nature · doi:10.1038/31729 · Cited by 1,425 · cited 1×
“However, the inactivation of cofilin (through phosphorylation by PAK via LIM kinase) causes it to lose its ability to bind to F-actin filament”
BackgroundCofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization
Yang, N., Higuchi, O., Ohashi, K., Nagata, K., Wada, A., Kangawa, K., Nishida, E., & Mizuno, K. (1998) · Nature · doi:10.1038/31735 · Cited by 1,294 · cited 1×
“However, the inactivation of cofilin (through phosphorylation by PAK via LIM kinase) causes it to lose its ability to bind to F-actin filament”
BackgroundOccurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159 · cited 1×
“The accumulation of Aβ or the altered processing of its precursor amyloid precursor protein (APP), encoded by the gene App located on chromosome 21, is associated with Alzheimer disease; and increases in the App gene dosage resulting from complete or segmental trisomy 21 lead to early spine and cognitive deficits and,…”
BackgroundSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811 · cited 1×
“Although it is possible that dendritic spine defects are merely secondary to upstream deficits in mental retardatio”
BackgroundCofilin Changes the Twist of F-Actin: Implications for Actin Filament Dynamics and Cellular Function
McGough, A., Pope, B., Chiu, W., & Weeds, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.771 · Cited by 761 · cited 1×
“In addition, cofilin induces conformational changes in actin that prevent other proteins from binding to acti”
BackgroundDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Self-citation
Cited by
Items 201–300 of 325
Danzer, K. M., Schnack, C., Sutcliffe, A., Hengerer, B., & Gillardon, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04933.x · Cited by 24
“Moreover, intracerebroventricular infusion with a PAK inhibitor caused memory deficits in adult mice strongly suggest that PAK signaling defects caused by oligomeric amyloid-b contribute to cognitive dysfunction in AD (Zhao et al. 2006).”
BackgroundSSH1 impedes SQSTM1/p62 flux and MAPT/Tau clearance independent of CFL (cofilin) activation
Fang, C. C., Woo, J. A., Liu, T., Zhao, X., Cazzaro, S., Yan, Y., Matlack, J. K., Kee, T. R., LePochat, P., & Kang, D. E. (2020) · Autophagy · doi:10.1080/15548627.2020.1816663 · Cited by 24
“Multiple studies have implicated the involvement of the F-actin-severing protein CFL (cofilin) in amyloid β (Aβ)induced dendritic spine shrinkage [26,27], accumulation of CFL-actin aggregates/rods in AD brains [28,29], and increased CFL activity in brains of AD patients [27,30] and AD mouse models [31].”
BackgroundChow, H. Y., Степанова, Д. С., Koch, J. N., & Chernoff, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013791 · Cited by 23
“A number of peptide based reagents, such as PID and cellpenetrating peptides based on the Nck or PIX binding regions of Pak, have been used to effectively block Pak function in cells and in vivo [39,40].”
MethodChuckowree, J. A., Zhu, Z., Brizuela, M., Lee, K. M., Blizzard, C. A., & Dickson, T. C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00223 · Cited by 25
Wang, Y., Song, X., Wang, Y., Huang, L., Luo, W., Li, F., Qin, S., Wang, Y., Xiao, J., Wu, Y., et al. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1794789 · Cited by 24
Marlin, J. W., Chang, Y. E., Ober, M., Handy, A., Xu, W., & Jakobi, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9326-6 · Cited by 23
“In contrast, reduced or aberrant full-length PAK-2 activity is involved in Alzheimer’s disease (Ma et al. 2008; Nguyen et al. 2008; Zhao et al. 2006 ).”
BackgroundRole of LIMK1-cofilin-actin axis in dendritic spine dynamics in Alzheimer’s disease
Paciello, F., Battistoni, M., Martini, S., Simone, C., Pastore, F., Sollazzo, R., Grassi, C., & Ripoli, C. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07741-7 · Cited by 22
“Indeed, the authors showed that A β oligomers can be responsible for PAK defects, leading to co fi lin and drebrin alterations and, further, that the expression of active PAK can exert a protective effect against the A β oligomers [85].”
Role of the p21-activated kinases (PAKs) in influenza A virus replication
Pascua, P. N. Q., Lee, J., Song, M., Park, S.-J., Baek, Y. H., Ann, B.-H., Shin, E., Kim, E., & Choi, Y. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.119 · Cited by 21
“Here, we found that the PAK selective inhibitor peptide PAK18, which has been used to interfere selectively with the activation of PAKs 1–3 in cell cultures and in vivo experiments [18,20,30], not only reduced infectious viral titers but also significantly suppressed ERK 1/2 phosphorylation (Fig.”
BackgroundA novel Rac1 GAP splice variant relays poly-Ub accumulation signals to mediate Rac1 inactivation
Huang, T. Y., Michael, S., Xu, T., Sarkeshik, A., Moresco, J. J., Yates, J. R., Masliah, E., Bokoch, G. M., & DerMardirossian, C. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-07-0565 · Cited by 19
Sbai, O., Khrestchatisky, M., Esclapez, M., & Ferhat, L. (2011) · Hippocampus · doi:10.1002/hipo.20914 · Cited by 22
“This assumption is supported by data from cultured hippocampal cells as well as in vivo experiments in which intracerebral injections of PAK inhibitors in rodents induce translocation of drebrin from the membrane to the cytosol (Zhao et al., 2006; Kojima and Shirao, 2007).”
BackgroundSPIN90 Phosphorylation Modulates Spine Structure and Synaptic Function
Cho, I. H., Kim, D. H., Lee, M.-J., Bae, J., Lee, K. H., & Song, W. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054276 · Cited by 20
“In addition, the fact that a number of neurological disorders, including Down’s syndrome, autism and Alzheimer’s disease, are closely associated with altered spine morphology and number highlights the importance of dendritic spine morphology [21,22,23,24].”
BackgroundLong-lasting efficacy of the cognitive enhancer Cytotoxic Necrotizing Factor 1
Borrelli, S., Musilli, M., Martino, A., & Diana, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.031 · Cited by 23
“, 2002, 2006) and social recognition (Zhao et al., 2006).”
Dobrigna, M., Poëa‐Guyon, S., Rousseau, V., Vincent, A., Toutain, A., & Barnier, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1123784 · Cited by 20
“A seminal experiment in mice showed that PAK inhibition causes cofilin anomalies and memory impairments similar to AD defects, strongly suggesting a causal role of PAK dysfunctions in AD-associated cognitive deficits (Zhao et al., 2006).”
BackgroundResultKim, H., Oh, J.-Y., Choi, S.-L., Nam, Y., Jo, A., Kwon, A., Shin, E.-Y., Kim, H. K., & Kim, H. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0230-6 · Cited by 19
“Down-regulation of PAK1 and PAK3, brain specific forms, has been reported in AD brain [13].”
BackgroundMajumder, P., Roy, K., Singh, B. K., Jana, N. R., & Mukhopadhyay, D. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027748 · Cited by 26
Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses
Bie, B., Wu, J., Foss, J. F., & Naguib, M. (2018) · Hippocampus · doi:10.1002/hipo.22955 · Cited by 18
“Ab oligomers appear to disturb the activity of p21-activated kinase-cofilin signaling, which contributes to the cognitive deficiency in AD (Zhao et al., 2006).”
BackgroundAlzheimer's amyloid story finds its star
Cole, G. M., & Frautschy, S. A. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.002 · Cited by 18
“Furthermore, oligomers can act via a major tau kinase glycogen synthase kinase 3b (GSK-3b) [12], fyn kinase [13] and p21-activated kinase (PAK) [ 14 ], and seem to be in equilibrium with intraneuronal Ab [15], another candidate cause of neurodegeneration in AD.”
BackgroundSelf-citationFerhat, L. (2012) · International Journal of Cell Biology · doi:10.1155/2012/474351 · Cited by 21
“This idea is supported by in vitro data obtained from cultured hippocampal neurons treated with soluble Aβ1-42 oligomer as well as in vivo experiments in which intracerebral injections of PAK inhibitors in rodents induce translocation of drebrin from the membrane to the cytosol [104].”
Zhu, Y., Kong, L., Han, T., Yan, Q., & Liu, J. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.1037 · Cited by 17
“PAK1 was one of the primary isoforms of PAK present in the brain, with a diffuse distribution across cell bodies and dendrites, and was implicated in the synaptic and cognitive dysfunctions in AD.(45) NRXN3 exhibited distinct essential pre‐ or postsynaptic functions in various brain regions and its dysregulation in pr…”
BackgroundDendritic spine morphology and dynamics in health and disease
Webb, D. J., Lee, S. N., & Zhang, H. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s82214 · Cited by 19
“molecular transport and trafficking in neurons, which could contribute to synaptic loss.(97,150) Moreover, AD patients have C el l H ea lth a nd C yt os ke le to n do w nl oa de d fr om h ttp s: //w w w .”
Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
Burgess, S., & Echeverría, V. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966632 · Cited by 19
Peters, E. C., Gossett, A. J., Goldstein, B., Der, C. J., & Reiner, D. J. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.004416 · Cited by 20
“2006), Alzheimer’s disease (McPhie et al. 2003; Zhao et al. 2006), and X-linked nonsyndromic mental retardation (Allen et al.”
BackgroundKastian, R. F., Minegishi, T., Baba, K., Saneyoshi, T., Katsuno‐Kambe, H., Saranpal, S., Hayashi, Y., & Inagaki, N. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109130 · Cited by 19
Kalirin‐7 prevents dendritic spine dysgenesis induced by amyloid beta‐derived oligomers
Xie, Z., Shapiro, L. P., Cahill, M. E., Russell, T. A., Lacor, P. N., Klein, W. L., & Penzes, P. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14311 · Cited by 17
Lu, C., Fan, Z., & Xing, D. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.010 · Cited by 15
Goikolea-Vives, A., & Stolp, H. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158220 · Cited by 16
Libeu, C. P., Descamps, O., Zhang, Q., John, V., & Bredesen, D. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040027 · Cited by 16
“Recent, complementary results argue that signaling events, some of which are mediated by the amyloid precursor protein (APP) itself, also play a crucial role in the development of the AD phenotype [2,9,10,11,12,13].”
BackgroundEarly growth response‐1‐mediated down‐regulation of drebrin correlates with loss of dendritic spines
Cho, C., MacDonald, R., Shang, J., Cho, M. J., Chalifour, L. E., & Paudel, H. K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14031 · Cited by 16
“In support, PAK over-expression in primary hippocampal neurons prevented drebrin loss despite the exposure to Ab (Zhao et al. 2006).”
BackgroundYang, X., Cao, Z., Zhang, J., Shao, B., Song, M., Han, Y., & Li, Y. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.09.145 · Cited by 15
Cong, C., Liang, W., Zhang, C., Wang, Y., Yang, Y., Wang, X., Wang, S., Huo, D., Wang, H., Wang, D., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13003 · Cited by 15
Interlacing the relevance of caspase activation in the onset and progression of Alzheimer’s disease
Dhage, P. A., Sharbidre, A. A., & Magdum, S. M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.11.008 · Cited by 14
“• PAK-cofilin signaling affects dendritic spine morphogenesis and actin dynamics (Zhao et al., 2006).”
BackgroundSoria-Fregozo, C., & Vega, M. I. P. (2011) · Neurología · doi:10.1016/j.nrl.2011.10.005 · Cited by 15
Janssen, L., Dubbelaar, M. L., Holtman, I. R., de Boer-Bergsma, J. J., Eggen, B. J. L., Boddeke, H. W. G. M., Deyn, P. P. D., & Dam, D. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.014 · Cited by 14
Tau kinase inhibitors protect hippocampal synapses despite of insoluble tau accumulation
Hinners, I., Hill, A., Otto, U., Michalsky, A., Mack, T. G. A., & Striggow, F. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.004 · Cited by 13
Cazzaro, S., Fang, C. C., Khan, H., Witas, R., Kee, T. R., Woo, J. A., & Kang, D. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.933979 · Cited by 12
Mi-mba, M.-F. O. M., Lebbadi, M., Alata, W., Julien, C., Émond, V., Tremblay, C., Fortin, S., Barrow, C. J., Bilodeau, J., & Calon, F. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100682 · Cited by 14
Self-citationDendritic Spines: Similarities with Protrusions and Adhesions in Migrating Cells
Vicente‐Manzanares, M., Hodges, J., & Horwitz, A. R. (2009) · The Open Neuroscience Journal · doi:10.2174/1874082000903020087 · Cited by 14
“actin filaments and cognitive decline [25, 26].”
Identification of Pak1 inhibitors using water thermodynamic analysis
Biswal, J., Jayaprakash, P., Kumar, R. S., Venkatraman, G., Poopandi, S., Rangasamy, R. E., & Jeyakanthan, J. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1567393 · Cited by 12
“…the role of Pak1’s associated with mental disorders (Allen et al., 1998; Kreis & Barnier, 2009; Meng, Meng, Hanna, Janus, & Jia, 2005; Peippo et al., 2007; Zhao et al., 2006), hypersensitivity issues, viral infections (Nguyen et al. (2006)), vascular and allergen-driven disorders as well.”
BackgroundBokoch, G. (2008) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000070.01 · Cited by 11
Neuronal insulin signaling and resistance: a balancing act of kinases and phosphatases
Sharma, M., Yadav, Y., & Dey, C. S. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0151 · Cited by 11
Soria-Fregozo, C., & Vega, M. I. P. (2012) · Neurología (English Edition) · doi:10.1016/j.nrleng.2011.10.006 · Cited by 14
“This has been correlated with PAK being a probable and potential participant in memory loss in Alzheimer disease.(63) Further genetic studies will identify new mutations that may affect the reordering of the actin cytoskeleton of dendritic spines.”
Dbo/Henji Modulates Synaptic dPAK to Gate Glutamate Receptor Abundance and Postsynaptic Response
Wang, M., Chen, P., Wang, C.-H., Lai, T.-T., Tsai, P.-I., Cheng, Y.-J., Kao, H.-H., & Chien, C. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006362 · Cited by 19
“Patholog-ically, PAK dysregulation also contributes to serious neurodegenerative diseases [53], such as Alzheimer disease [54, 55], Huntington’s disease [56, 57] and X-linked mental retardation [58–60].”
Shen, J., Wang, D., & Wang, R. (2012) · PubMed · Cited by 13
Parent, A., & Thinakaran, G. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/825918 · Cited by 11
“A role of PAK in cognitive deficits of AD has also been reported [97].”
BackgroundDual role of cofilin in APP trafficking and amyloid‐β clearance
Liu, T., Woo, J. A., Yan, Y., LePochat, P., Bukhari, M. Z., & Kang, D. E. (2019) · The FASEB Journal · doi:10.1096/fj.201901268r · Cited by 10
Actin Cytoskeleton at the Synapse: An Alzheimer's Disease Perspective
Haseena, P. A., Basavaraju, N., Gupta, A., & Kommaddi, R. P. (2025) · Cytoskeleton · doi:10.1002/cm.21993 · Cited by 10
“Studies have shown that this dysregulation of the PAK- LIMK-cofilin pathway is associated with synaptic loss and cognitive decline in AD models (Heredia et al. 2006; Zhao et al. 2006).”
Cazzaro, S., Zhao, X., Zhao, V. K., Kim, Y. K., & Woo, J. A. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad006 · Cited by 9
Mercado-Pimentel, M. E., Miller, C., Rolph, D. N., Villalobos, E. F., Dunn, A. M., Mohan, P. M., Igarashi, S., Liu, X., Yrun-Duffy, M., Patel, N. K., et al. (2016) · Otology & Neurotology · doi:10.1097/mao.0000000000001247 · Cited by 9
Krivinko, J. M., Erickson, S. L., Abrahamson, E. E., Wills, Z. P., Ikonomović, M. D., Penzes, P., & Sweet, R. A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.02.006 · Cited by 9
“Activated type I PAKs (PAK1, PAK2, and PAK3) signal downstream of kalirin and have been reported to be reduced in AD, in APPswe transgenic mice, and to contribute to cognitive impairments (Zhao et al., 2006).”
Effect of empagliflozin on cytoskeletal repair in the hippocampus of obese mice
Chen, X., Ma, L., Zhao, J., Pan, X., & Chen, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1000839 · Cited by 9
“However, recent evidence suggests that PAKs are also critical for neuronal development, axon guidance, and brain-related functions and behaviors (Zhao et al., 2006; Cong et al., 2021).”
BackgroundTGFβ2-induced changes in LRP-1/TβR-V and the impact on lysosomal Aβ uptake and neurotoxicity
Eslami, P., Johnson, M. F., Terzakaryan, E., Chew, C., & Harris‐White, M. E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.086 · Cited by 9
Self-citationBarnes, N. Y., Shi, J., Yajima, H., Thinakaran, G., & Parent, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05102.x · Cited by 9
“Recently, a role of PAK in cognitive deficits of AD has also been reported (Zhao et al. 2006).”
The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 10
Remodeling of Actin Filaments by Drebrin A and Its Implications
Grintsevich, E. E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56550-5_5 · Cited by 8
Chan, H. H., Leong, Y. Q., Voon, S. M., Pan, M. L., Leong, C. O., Lim, C. L., & Koh, R. Y. (2021) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.9.4.417 · Cited by 8
“the expression of Cdc42 and its downstream effector, p21-activated kinase, declined after treating cells with oligomeric Aβ25–35 and Aβ1–42, respectively (37-39).”
BackgroundResilience mechanisms underlying Alzheimer’s disease
Chew, C. S., Jy, L., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-024-01507-4 · Cited by 7
“This is consistent with other previous studies indicating that in the hippocampus and temporal cortex, PAK1 and PAK3 isoforms in the cytosol are decreased during AD progression (Zhao et al. 2006).”
Stress Elicits Contrasting Effects on Rac1-Cofilin Signaling in the Hippocampus and Amygdala
Bose, M., Nawaz, M. S., Pal, R., & Chattarji, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.880382 · Cited by 7
The Evaluation of Rac1 Signaling as a Potential Therapeutic Target of Alzheimer’s Disease
Wang, H., Yamahashi, Y., Riedl, M., Amano, M., & Kaibuchi, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511880 · Cited by 8
“Discussion Dysfunctional Rac1 signaling has been implicated in AD pathogenesis and ADassociated learning deficits [32,33].”
BackgroundTargeting p21-activated kinase 1 for development of a novel anti-arrhythmic drug class
He, Y. H., Grassam-Rowe, A., Lei, M., & Bae, J. S. H. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0285 · Cited by 6
“For example, loss of PAK1 has been indicated to be associated with the progression of neurodegenerative disorders, particularly Alzheimer’s disease [72].”
BackgroundUpadhyaya, Y., Xie, L., Salama, P., Cao, S., Nho, K. T., Saykin, A. J., Yan, J., & Initiative, A. D. N. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0689-y · Cited by 10
Chen, H.-S. V., & Majdi, M. (2009) · Journal of Receptor Ligand and Channel Research · doi:10.2147/jrlcr.s4498 · Cited by 7
Vatsa, N., Brynildsen, J. K., Goralski, T. M., Kurgat, K., Meyerdirk, L. K., Breton, E., DeWeerd, D., Brasseur, L., Turner, L., Becker, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.619411 · Cited by 5
Small GTPases control macropinocytosis of amyloid precursor protein and cleavage to amyloid-β
Chiu, J., Krupa, J. M., Seah, C., & Pasternak, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31077 · Cited by 5
“Downstream of Rac1, defects in the activity and localization of the p21-activated kinases (PAKs) have been observed in transgenic AD mouse models and resulted in cognitive impairments and dendritic spine alterations [58].”
BackgroundRas, RhoA, and vascular pharmacology in neurodevelopment and aging
Nussinov, R., Jang, H., & Cheng, F. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105883 · Cited by 4
Meng, G., Tian, C., Wang, H., Xu, Y., Zhang, B., Shi, Q., Gao, C., Chen, C., Fan, X., Wang, J., et al. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0342-5 · Cited by 4
“Misregulation of cellular microtubule is observed in some human neurodegenerative disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [27, 28].”
Marlin, J. W., Chang, Y. E., & Jakobi, R. (2010) · Journal of Cell Death · doi:10.4137/jcd.s4611 · Cited by 4
Cytoskeletal Organization: Actin
Abouelezz, A. M., Minkeviciene, R., & Hotulainen, P. (2016) · Springer eBooks · doi:10.1007/978-4-431-56050-0_2 · Cited by 4
Hogestyn, J. M., Salois, G., Xie, L. H., Apa, C., Youngyunpipatkul, J., Pröschel, C., & Mayer-Pröschel, M. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103770 · Cited by 3
Chen, H., Li, M., & Cheng, C. Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56550-5_17 · Cited by 3
“For instance, drebrin has been shown to oppose the ability of cofilin to promote actin severing and depolymerization through competitive binding to Factin and vice versa (Zhao et al. 2006; Grintsevich and Reisler 2014).”
BackgroundInfluentialAsai, T. T., & Sugiyam, T. (2007) · PubMed · Cited by 4
Methods for Controlling Small GTPase Activity
Faulkner, B. M., He, Y., Sitrin, D., & Stains, C. I. (2025) · ChemBioChem · doi:10.1002/cbic.202500156 · Cited by 2
Functional Differences Between Neuronal and Non-neuronal Isoforms of Drebrin
Srapyan, S., Mkrtchyan, M., Berlemont, R., & Grintsevich, E. E. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169015 · Cited by 2
“2,26 Furthermore, a previous report indicated the strong protection of actin filaments against cofilin-mediated severing by DrbA.”
Sánchez‐Gracia, A., Guirao‐Rico, S., Hinojosa‐Álvarez, S., & Rozas, J. (2017) · Journal of Neurogenetics · doi:10.1080/01677063.2017.1398241 · Cited by 2
“…neuronal survival (Mielke, Taghibiglou, & Wang, 2006; Valenciano, Corrochano, de Pablo, de la Villa, & de la Rosa, 2006), and in some neurological diseases, including Parkinson ’ s disease, Schizophrenia, and Alzheimer among others (Steen et al ., 2005; Takahashi et al ., 1996; Zhao et al ., 2006).”
BackgroundDefects in Rho GTPase Signaling to the Spine Actin Cytoskeleton in FMR1 Knockout Mice
Lauterborn, J. C., & Gall, C. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00014-7 · Cited by 4
Biomarker for Alzheimer's Disease
Haas, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805364-5.00015-9 · Cited by 2
Amphetamine-induced dopaminergic toxicity:
Jobes, M. L. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3ws8tkp · Cited by 3
“To date, family A PAKs are known to be essential in the structure and function of the central nervous system and have been found to play a role in mental retardation, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS; Lou Gherig’s disease) (Boda et al., 2004; Tudor et al., 2005; Zhao et al., 2006; Ma et al.,…”
BackgroundThe Role of Rac1 in Synaptic Plasticity, Learning and Memory
Bongmba, O. Y. N. (2012) · Cited by 3
Daniel, A., Palacios-García, I., & González-Billault, C. E. (2013) · InTech eBooks · doi:10.5772/54038 · Cited by 1
“Moreover, the treatment with oligomers of Aβ1-40 has the oppo‐ site effect, decreasing the phosphorylation of PAK, indicating that oligomeric forms may be responsible for the overall reduction in PAK phosphorylation [92].”
BackgroundInfluentialYamahashi, Y., Tsuboi, D., Funahashi, Y., & Kaibuchi, K. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2265067 · Cited by 1
“Dysfunction of group I PAKs has been associated with AD because of their inactivation in AD patients’ brains [79].”
BackgroundPAK1 expression protects cellular and behavioral defects in animal models of Parkinson’ s disease
Kim, J., Lee, K., Kim, H. J., Oh, W., & Kim, H. K. (2026) · Molecular Brain · doi:10.1186/s13041-026-01320-3 · Cited by 1
“In human brains with AD, levels of PAK1 and PAK3 were significantly reduced and phosphorylated PAKs (pPAKs) were redistributed [4].”
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
Association of the EPHA1 gene polymorphism with idiopathic mild intellectual disability
Gulkovskyi, R. V., & Лившиц, Л. А. (2015) · Biopolymers and Cell · doi:10.7124/bc.0008eb · Cited by 1
“Our results suggest that SNPs (rs11768549, rs11767557, rs11771145) in the EPHA1 gene are associated with idiopathic mild intellectual disability.”
BackgroundInfluentialRas-related C3 botulinum toxin substrate 1 role in pathophysiology of neurological diseases
Le, N. M., & Li, J. (2022) · Brain Hemorrhages · doi:10.1016/j.hest.2022.05.005 · Cited by 2
Alsegiani, A. S., & Shah, Z. A. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.09.003 · Cited by 1
PAK1 in Alzheimer’s and Huntington’s Diseases
Ma, Q., Yang, F., Frautschy, S. A., & Cole, G. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-407198-8.00006-0 · Cited by 1
Self-citationSoltani, A. (2014) · theses.fr (ABES) · doi:10.70675/26a65a76zeeb4z4c2fz8664z90cf5fd31f88 · Cited by 1
Mekkittikul, M., Zhu, C., Danna, B. T., Zuo, X., Rios, A., Yang, K., Villanueva, M., Agarwal, D., Castro, D., Gu, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.651373 · Cited by 1
“Slides were de-paraffinized and quenched using 0.3% (v/v) hydrogen peroxide in methanol for 35 minutes.”
InfluentialSelf-citationAradi, S. D. (2011) · Digital Commons - University of South Florida (University of South Florida)
Natural or Synthetic Therapeutics That Block PAKs
Maruta, H., Messerli, S. M., & Jha, R. K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-407198-8.00003-5
Rastreo Celómico mediante Genotecas de expresión de reguladores de la GTPasa Rac1
Castro-Castro, A. (2010) · Gredos (University of Salamanca) · doi:10.14201/gredos.76423
Actin cytoskeleton in dendritic spine
Hanamura, K., & Shirao, T. (2007) · Folia Pharmacologica Japonica · doi:10.1254/fpj.130.352
Methods for treating neurological conditions (WO2011159945)
Meissner, W. G. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.699524
“PAK1-3 levels are reduced in AD patients and transgenic mouse models of AD [4,39].”
BackgroundInfluentialJessen, A. L. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-406 · Cited by 1
Role of the Slingshot-Cofilin and RanBP9 pathways in Alzheimer's Disease Pathogenesis
Woo, J. A. (2015) · Digital Commons - University of South Florida (University of South Florida)
Lewis, S. A. (2015) · UA Campus Repository (The University of Arizona) · Cited by 1
Chronophin and Slingshot Cofilin Phosphatases in Cytoskeletal Regulation
DerMardirossian, C. M., Huang, T. Y., & Bokoch, G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00106-6
A novel neurotrophic drug for cognitive enhancement and Alzheimer?s disease
Prior, M. (2013) · Journal of Alzheimers Disease & Parkinsonism
McGowan, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1874
Cellular models of human brain disorders from skin to brain
Shahsavani, M. (2018) · Figshare
Metadata
- Authors
- Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., Weisbart, R. H., Teter, B., Frautschy, S. A., & Cole, G. M.
- Affiliations
- VA Sepulveda Ambulatory Care Center (US)
- University of California, Los Angeles (US)
- Centre hospitalier de l'Université Laval (CA)
- The University of Osaka (JP)
- Corresponding author
- Cole, Greg M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-01-15
- Volume
- 9
- Issue
- 2
- Pages
- 234-242
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1985086842
- Cited by
- 317
- References
- 52
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 15 · 2017: 22 · 2016: 16 · 2015: 9 · 2014: 20 · 2013: 22 · 2012: 23
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG16570, AG-10415, R01AG016793, P50AG016570, R01AG013741, P50-AG 16570, P50-AG05142, R01AG010685, AG022080, P60AG010415, P50AG005142, AG10685, AG16793, R01 AG13741, R01AG022080)
- National Institute of Neurological Disorders and Stroke (R01NS043946, NS43946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- p21-activated kinase, Alzheimer's disease, cognitive impairment, dendritic spines, cofilin, drebrin, actin dynamics, amyloid-beta, amyloid-beta oligomers, hippocampal neurons, memory impairment, synaptic dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Cognition Disorders, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Neuropeptides, Amyloid beta-Peptides, Protein Serine-Threonine Kinases, Dendritic Spines, Actin Depolymerizing Factors, Mice, Rats, p21-Activated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.